Not applicableStudy completedNCT01461070What this trial is testingIntestine Bacteria and Breast Cancer RiskWho this might be right forBreast Neoplasms National Cancer Institute (NCI) 175
Post-approval studies (Phase 4)Study completedNCT06633705What this trial is testingChanges in Neighbouring Microbiota in Genitourinary SyndromeWho this might be right forGenitourinary Syndrome of Menopause Koc University Hospital 31
Early research (Phase 1)Looking for participantsNCT04872166What this trial is testingBTX-A51 in People With Advanced Solid Tumor and Breast CancerWho this might be right forAdvanced Solid TumorMetastatic Breast Cancer Edgewood Oncology Inc. 112
Not applicableEnded earlyNCT02149173What this trial is testingF-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyWho this might be right forEstrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 29
Not applicableStudy completedNCT03523195What this trial is testingExercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsWho this might be right forAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+16 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT03633331What this trial is testingPalbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7 Alliance for Clinical Trials in Oncology 93
Testing effectiveness (Phase 2)Study completedNCT00608972What this trial is testingPhase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Rutgers, The State University of New Jersey 31
Not applicableStudy completedNCT06344767What this trial is testingPositive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary TumorWho this might be right forBreast Cancer Fudan University 19
Not applicableStudy completedNCT01293032What this trial is testingHormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancerWho this might be right forDuctal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage II Breast Cancer+4 more Virginia Commonwealth University 59
Testing effectiveness (Phase 2)Looking for participantsNCT06150898What this trial is testingKetorolac and Pregabalin Effects on breaSt Cancer (KePreSt)Who this might be right forEarly-stage Breast CancerEstrogen-receptor-positive Breast Cancer Jules Bordet Institute 112
Early research (Phase 1)Study completedNCT01009437What this trial is testingRitonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerWho this might be right forBreast Cancer Masonic Cancer Center, University of Minnesota 28
Testing effectiveness (Phase 2)Ended earlyNCT00592007What this trial is testingStudy Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Carcinoma Lyudmila Bazhenova, M.D. 7
Early research (Phase 1)Active Not RecruitingNCT01327781What this trial is testingZ-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast CancerWho this might be right forHER2/Neu PositiveRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7+1 more National Cancer Institute (NCI) 62
Not applicableStudy completedNCT00060736What this trial is testingThe Effects of Estrogen Withdrawal on Mood Symptoms in WomenWho this might be right forPerimenopausal DepressionPost MenopausalHealthy+1 more National Institute of Mental Health (NIMH) 60
Testing effectiveness (Phase 2)Study completedNCT02007512What this trial is testingEfficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerWho this might be right forBreast Cancer Pfizer 247
Testing effectiveness (Phase 2)WithdrawnNCT06938711What this trial is testingA Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Context Therapeutics Inc.
Large-scale testing (Phase 3)Study completedNCT02419729What this trial is testingEvaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal AtrophyWho this might be right forVulvovaginal Atrophy Faculdade de Medicina do ABC 45
Testing effectiveness (Phase 2)Study completedNCT04150731What this trial is testing16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast CancerWho this might be right forBreast Cancer University of Aarhus 8
Testing effectiveness (Phase 2)Study completedNCT03560531What this trial is testingZN-c5 in Subjects With Breast CancerWho this might be right forBreast Cancer Zeno Alpha Inc. 181
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107What this trial is testingCarboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerWho this might be right forBreast CarcinomaBreast LumpEdema+8 more M.D. Anderson Cancer Center 42